
Lactulose is a non-absorbable synthetic disaccharide used worldwide as a gentle osmotic laxative and as first-line therapy for hepatic encephalopathy (HE) in people with cirrhosis. Because it is not digested in the small intestine, lactulose reaches the colon, where gut bacteria ferment it into organic acids. Those acids draw water into the bowel to soften stools and also acidify the colon, trapping ammonia and lowering its absorption—key for preventing and treating HE. At typical doses, lactulose is well tolerated, available as a sweet syrup or crystalline powder, and safe for longer-term use under medical guidance. You will see it recommended for chronic constipation, opioid-related constipation alongside other agents, and for secondary prevention after an episode of overt HE. This guide translates pharmacology into practical steps: who benefits most, how it works, how to take it correctly, what dosages are used for different conditions, common pitfalls that reduce its effectiveness, and safety considerations for adults, older adults, children, and special populations.
Key Insights
- Eases chronic constipation by increasing stool water and improving stool frequency and consistency.
- Reduces ammonia absorption and helps prevent recurrent hepatic encephalopathy in cirrhosis.
- Typical adult constipation dose: 10–20 g (≈15–30 mL syrup) once daily, titrated up to 40–60 mL; HE dose often 30–50 mL three times daily to target 2–3 soft stools/day.
- Avoid use without medical advice if you have galactose intolerance, need a low-galactose diet, or have unexplained abdominal pain or suspected bowel obstruction.
Table of Contents
- What is lactulose and how it works
- Who benefits and when to use it
- How to take lactulose correctly
- Dosage and timing by condition
- Common mistakes and troubleshooting
- Safety, side effects, and who should avoid it
- Evidence snapshot and FAQs
What is lactulose and how it works
Chemical and pharmacology basics
Lactulose is a synthetic sugar made by rearranging lactose (milk sugar) so that galactose is linked to fructose. Humans lack the enzymes to digest this linkage in the small intestine. As a result, lactulose passes intact to the colon, where resident bacteria ferment it into short-chain organic acids—primarily lactic, acetic, and formic acids. That fermentation explains both the therapeutic effect and the most common side effects (gas and cramping during dose titration).
Mechanisms that drive benefits
- Osmotic action for constipation: The organic acids and unabsorbed sugars draw water into the colonic lumen and increase stool bulk. Transit is accelerated, stool form softens, and the urge to strain decreases.
- Ammonia-lowering effect in hepatic encephalopathy: Acidification of the colonic contents shifts ammonia (NH₃) to the charged ammonium ion (NH₄⁺), which is poorly absorbed. Faster transit also reduces the time bacteria have to produce ammonia. The result is a reduction in blood ammonia and improved neurocognitive function in people with cirrhosis who are prone to HE.
- Microbiome modulation: Regular dosing favors saccharolytic bacteria and reduces urease-producing species that generate ammonia. While lactulose is not a probiotic, its prebiotic-like fermentation contributes to its HE benefits and may modestly support bowel regularity over time.
What makes lactulose different from other laxatives
- It is non-stimulant and generally suitable for chronic use under guidance.
- Onset is not immediate; typical bowel movement response occurs in 24–48 hours after starting or changing the dose.
- The dose target is functional, not fixed: for constipation and HE, the goal is 2–3 soft stools per day without diarrhea or cramping.
Forms and availability
- Syrup (solution): Most common—often 10 g per 15 mL. The syrup is sweet and viscous; many people mix it with water, milk, or juice.
- Crystals/powder for solution: Dissolved in water just before use; helpful when precise gram dosing is desired or to reduce sugar load from syrup excipients.
Who benefits and when to use it
Chronic idiopathic constipation (CIC) in adults
Lactulose is a guideline-supported option for CIC. It can be started early in a stepwise plan that also includes fiber, hydration, and behavioral measures. Some people respond better to polyethylene glycol (PEG), but lactulose remains valuable where PEG is unavailable, not tolerated, or when a clinician prefers its colonic acidification effects. Expect improvements in stool frequency, consistency, and ease of passage after 1–3 days, with further gains as the dose is tuned.
Opioid-related constipation (ORC)
Because opioids slow colonic transit, an osmotic agent is often combined with a stimulant laxative. Lactulose can be one component of that plan, particularly when PEG causes bloating or is impractical. If inadequate relief persists despite combination therapy, peripherally acting μ-opioid receptor antagonists (e.g., naloxegol) may be added by a clinician.
Cirrhosis with minimal or overt hepatic encephalopathy
Lactulose is first-line therapy for treatment and prevention of HE episodes. It reduces neurocognitive impairment, hospital readmissions, and risk of recurrent episodes, especially when combined with rifaximin in patients who have already had overt HE. In the acute setting, higher or more frequent doses—and occasionally rectal administration—are used to rapidly achieve 2–3 soft stools/day while avoiding frank diarrhea and electrolyte shifts.
Post-surgical or postpartum constipation
When straining is undesirable (e.g., after hemorrhoid surgery, pelvic floor repair, or C-section), lactulose’s stool-softening profile is often preferred. Start low; titrate to comfort.
Pediatrics
Lactulose is widely used for functional constipation in children, with dosing adjusted by weight and response. Because taste can be a barrier, mixing with juice or milk and using a syringe for accurate dosing helps families maintain adherence. Always follow pediatric guidance on dosing and duration.
When lactulose is not the best choice
- Severe, sudden-onset abdominal pain, fever, or vomiting—these require urgent evaluation, not laxatives.
- Chronic constipation unresponsive to first-line measures—consider diagnostic work-up for defecatory disorders or slow-transit constipation and advanced therapies.
- Frequent diarrhea or urgency—an osmotic laxative may aggravate symptoms.
How to take lactulose correctly
Start with purpose and a plan
Decide whether the goal is constipation relief or HE control. That determines the starting dose, titration, and targets you watch.
General administration tips
- Measure precisely. Use the provided cup or an oral syringe; kitchen spoons are inaccurate.
- Mix to taste. Dilute the syrup in water, milk, or juice to reduce sweetness and improve tolerance.
- Time it consistently. Take at the same time(s) daily; for once-daily dosing, many prefer morning use to align with natural colonic activity.
- Hydrate. Aim for adequate fluids unless restricted—for most adults, 1.5–2 L/day spread across the day helps osmotic agents work comfortably.
- Titrate every few days. Because effect ramps over 24–48 hours, adjust no faster than every 1–2 days.
Constipation: an example titration
- Day 1–2: 10–20 g (≈15–30 mL syrup) once daily with breakfast.
- Day 3–4: If stools remain hard or infrequent, increase by 10 g (≈15 mL).
- Day 5+: Continue small increases every 1–2 days until you reach regular, soft stools. Most adults settle between 20–40 g/day (≈30–60 mL), divided once or twice daily.
- Maintenance: When regular, ease down to the lowest dose that maintains comfort.
Hepatic encephalopathy: practical approach
- Acute management (under medical care): Doses may be given every 1–2 hours until 2–3 soft stools have occurred, then reduced to maintenance. If oral dosing is not possible, lactulose solution can be administered rectally (for example, diluted and retained with nursing support).
- Maintenance: Typically 30–50 mL three times daily, with real-time adjustments to keep stooling in the 2–3 soft stools/day range. Add rifaximin if HE recurs despite optimized lactulose, per clinician guidance.
Taste and tolerance tips
- Chill the dose, use a straw, and rinse the mouth afterward to reduce sweetness.
- For gas or cramping during the first week, maintain your current dose for several days before increasing; symptoms often fade as the microbiota adapt.
Adherence check-ins
- Keep a stool diary (frequency, form using Bristol Stool Scale, urgency, cramping).
- Review other contributors: fluid intake, fiber type/amount, activity, new medications (e.g., anticholinergics, iron).
Dosage and timing by condition
Important: Doses below are typical ranges for adults unless otherwise noted. Always follow the label and your clinician’s instructions.
Chronic constipation (adults)
- Starting dose: 10–20 g once daily (≈15–30 mL syrup).
- Titration: Increase by 10 g (≈15 mL) every 1–2 days as needed.
- Usual range: 20–40 g/day (≈30–60 mL/day), in 1–2 divided doses.
- Onset: Usually 24–48 hours after starting or adjusting the dose.
Hepatic encephalopathy (adults with cirrhosis)
- Acute titration (supervised): Doses as often as every 1–2 hours until 2–3 soft stools occur.
- Maintenance: 30–50 mL three times daily, adjust to maintain 2–3 soft stools/day without diarrhea.
- Add-on therapy: Rifaximin is commonly added if HE recurs or if goals are not met on lactulose alone.
Pediatrics (functional constipation)
- Dosing is weight-based and individualized. A practical range used in pediatrics is approximately 0.7–2 g/kg/day divided 1–2 times daily. Because products and national guidelines vary, parents should follow the exact dosing provided by their pediatric clinician or on local formularies.
- Infants and toddlers: Start low; taste and gas can limit adherence. Mixing with breast milk or formula (if permitted) or a small amount of juice can help.
Older adults
- Start at the low end (e.g., 10 g/day) and titrate slowly to reduce gas and cramping. Ensure fall-risk precautions if stools become urgent.
Renal impairment
- No dose adjustment is typically required because lactulose is minimally absorbed. Prioritize fluid and electrolyte monitoring if diarrhea occurs.
Pregnancy and breastfeeding
- Lactulose has very limited systemic absorption and is generally considered compatible during pregnancy and lactation when needed for constipation. As with all medications in pregnancy, use the lowest effective dose and involve your obstetric clinician.
Diabetes
- Although systemic absorption is minimal, the syrup contains small amounts of galactose, lactose, and other sugars. Monitor glucose if doses are high or frequent; consider powder formulations to reduce sugar exposure.
Rectal administration (HE, when oral not possible)
- Under clinical supervision, lactulose solution may be diluted in water and given as a retention enema, repeated as needed until soft stooling begins, then transitioned back to oral dosing. This is not typically used for routine constipation.
Common mistakes and troubleshooting
Mistake 1: Expecting immediate relief
Lactulose’s onset is 24–48 hours. Increasing the dose too quickly in the first day mainly produces gas and cramping without earlier relief.
Mistake 2: Not titrating to a target
For both constipation and HE, the practical target is 2–3 soft stools/day. If you are below that after two days, increase by a small step; if you overshoot into diarrhea, decrease.
Mistake 3: Skipping hydration
Osmotic laxatives work best when you are well hydrated. Unless on fluid restriction, aim for regular fluids spread across the day.
Mistake 4: Abandoning therapy during the “gas week”
As the microbiota adapt, flatulence and mild cramps often settle. Holding a dose steady for 3–4 days before the next increase reduces discomfort.
Mistake 5: Using stimulants alone for chronic constipation
Stimulant laxatives can help, but over-reliance may lead to cramping and urgency. Many people do better on an osmotic base (such as lactulose or PEG) with or without a low-dose stimulant.
Mistake 6: Ignoring interacting conditions
Unrecognized iron supplements, anticholinergics, calcium, or low-fiber diets can blunt any laxative’s effect. Review your full medication and supplement list.
Troubleshooting quick fixes
- Too loose: Reduce the dose by 5–10 g (≈7.5–15 mL) or drop one daily dose; re-evaluate in 48 hours.
- Cramping/gas: Split the dose (morning and evening), mix with food or milk, and avoid rapid increases.
- No effect after a week: Confirm daily dose, timing, hydration, and dietary fiber. Consider switching to or adding PEG per guideline advice, or seek medical review for other causes.
Safety, side effects, and who should avoid it
Common side effects (often dose-related and transient)
- Flatulence, abdominal cramping, bloating—especially during the first week or after dose increases.
- Loose stools or diarrhea if the dose overshoots the individual target.
- Taste issues from syrup sweetness; mitigated by dilution or chilling.
Less common but important
- Dehydration and electrolyte disturbances (e.g., hypokalemia, hypernatremia) with persistent diarrhea—more likely in frail adults, those with limited fluid intake, or on diuretics.
- Nausea or vomiting at higher doses or when taken on an empty stomach in sensitive users.
Allergy and intolerance
- True allergy is rare. However, the syrup contains residual galactose and lactose; people with galactosemia, severe lactose intolerance, or those advised to follow low-galactose diets should seek alternatives or use powder preparations if appropriate.
Drug interactions
- Clinically significant interactions are uncommon.
- Combining with other laxatives can increase the risk of diarrhea; if using a stimulant (e.g., senna, bisacodyl), start with lower doses of each and titrate thoughtfully.
- Antacids with magnesium may add to the osmotic effect; monitor stool consistency.
Who should avoid lactulose or get medical advice first
- Suspected bowel obstruction, unexplained abdominal pain, or GI bleeding.
- Severe dehydration or electrolyte imbalance.
- People unable to access a bathroom safely (fall risk) until the dose is stable.
- Infants and young children without guidance.
- Cirrhosis with severe diarrhea or active infection—doses should be managed within a clinical plan.
Overdose signs
- Repeated, watery diarrhea; marked abdominal cramping; lightheadedness; muscle weakness (possible hypokalemia). Stop doses and seek medical advice; rehydrate as directed.
Driving and work safety
- Lactulose does not impair cognition or coordination, but sudden urges can occur when dose is being adjusted. Plan doses around work or travel until your response is predictable.
Evidence snapshot and FAQs
Evidence at a glance
- Constipation: Modern joint guidelines for adults with chronic idiopathic constipation support lactulose as an evidence-based osmotic option, often with conditional strength compared with strong recommendations for PEG and certain secretagogues.
- Hepatic encephalopathy: Practice guidelines and systematic reviews support non-absorbable disaccharides (lactulose, lactitol) as first-line therapy for treatment and prevention. Benefits include lower HE recurrence and improvements in mental status; adding rifaximin reduces recurrence further in high-risk patients.
- Onset and pharmacokinetics: Clinical labels consistently note that 24–48 hours may be needed to achieve the desired bowel movement after starting or adjusting lactulose.
- Safety: Most adverse effects are GI and dose-related, with dehydration and electrolyte disturbances as preventable complications of overtreatment.
Frequently asked questions
- How fast will it work for constipation?
Expect changes within 1–2 days. Do not keep increasing doses every few hours; adjust every 1–2 days based on stool response. - What stool pattern should I aim for in HE?
Target 2–3 soft stools per day without watery diarrhea. That range is associated with improved cognition and fewer HE recurrences. - Can I take it if I have diabetes?
Yes, with caveats. Systemic absorption is minimal, but the syrup vehicle contains sugars. Monitor if doses are high, or use powder formulations as advised. - Is it safe during pregnancy or breastfeeding?
Generally considered acceptable when needed for constipation because absorption is minimal. Use the lowest effective dose and consult your obstetric clinician. - What if gas is a problem?
Split the dose, slow the titration, take with food, and give it several days for your gut to adapt. Many people find gas subsides after the first week. - How does it compare with PEG?
PEG often has stronger evidence and fewer gas symptoms, but lactulose remains effective, widely available, and essential for HE—a role PEG does not share. - Can children use lactulose?
Yes, under pediatric guidance with weight-based dosing. If there is pain, vomiting, or blood in the stool, seek care before giving any laxative.
References
- American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation 2023 (Guideline)
- Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by AASLD and EASL 2014 (Guideline)
- Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis 2016 (Systematic Review)
- Label: LACTULOSE solution 2025 (Drug Label)
- How and when to take lactulose 2022 (Official Guidance)
Disclaimer
This information is educational and not a substitute for professional medical advice, diagnosis, or treatment. Always use lactulose under the guidance of a qualified clinician, especially if you have cirrhosis, are pregnant or breastfeeding, are older with fall risk, or take diuretics or other medications that affect hydration and electrolytes. Seek urgent care for severe abdominal pain, vomiting, GI bleeding, signs of dehydration, or confusion. For chronic constipation unresponsive to first-line measures, ask your clinician about further evaluation and alternative therapies.
If you found this guide useful, please consider sharing it on Facebook, X (formerly Twitter), or your preferred platform, and follow us for future evidence-based health articles. Your support helps us continue producing quality content.









